醫療器材

"Biomdcare’s Osteoporosis AI Screening Assistant is the first ever AI model to use hip X-ray image as the source to perform fast screening on Osteoporosis and has achieved 90% of accuracy. This Osteoporosis AI Screening Assistant can be equipped on mobile X-ray buses to help expand the screening area to communities and rural areas.；Mobiosense is leveraging the semiconductor expertise in Taiwan to develop a semiconductor biomolecule sensor that can directly detect biomolecules (proteins, DNA, etc) without any fluorescent or electrochemical reagents, enabling portable yet high sensitivity biotesting at the point of care without bulky, hard to use instruments；The Smart Hearing Solution combines innovative product design (IP) and artificial intelligence systems (AI) to enhance the quality of the user's hearing. It solves the problem that traditional hearing aids are completely unclear when talking to many people. The core technology of the product includes ""voice beamforming system design"", ""computer vision analysis technology"", ""AI deepening neural network"" to solve the problem of multi-human ""language noise"" noise reduction for international manufacturers (cocktail party effect)."

Our results have demonstrated that our tissue gel can effectively promote angiogenesiswound healing in diabetic wounds. Our product prototype will be a powerful therapeutic product to treat diabetic foot ulcersgo further to rescue diabetic patients from amputation.

Epidermolysis bullosa (EB) is an inherited blistering skin diseaseis also one of the most "urgent, severe, difficultrare" diseases. Since there are at least 21 disease-causing genes involved in EB with markedly variable manifestations, it is particularly difficult for accurate diagnosis. In recent years, next generation sequencing (NGS) has been widely applied in the genetic diagnosis of rare hereditary disorders. The EB team in NCKU established the protocol of EB diagnosis by combining NGSvarious tools of pathologymolecular studies. Till now, we have completed the genetic diagnosis for more than 50 Taiwanese EB patients.

EPICAn is a novel technique that uses liquid biopsy for epigenetic analysis. Using methylation-specific PCR method to analyze specific gene methylation of cell-free DNA in plasma for early detection of breast cancer. The advantages of this technology are 1. High accuracy 2. Low false positive rate 3. Low-invasive 4. less limitation 5. Available for routine continuous detection 6. Monitoring cancer changes 7. Aided diagnosis 8. Automated process 9. Easy-to-operate 10. Rapid analysis. It is expected that EPICAn technique can increase the accuracy of early detection of breast canceraid clinicians diagnosis.

During arthroscopic surgery, the anchor suture is easy to tangleunable to fix the soft tissue using conventional one lumen cannula. Thus we design a novel “Double lumen cannula” containing a flexible septum inside the cannula which can separatechange the cannula volume dynamically into two lumen. This would decrease the surgical timesoft tissue injury,improve the security of su

Here, we introduce an electricity-free centrifuge platform based on a manual centrifuge. The provided centrifugal force is sufficient to produce a plasma purity of 99 separated in as little as 2−3 min. We then performed an immunoassay on a paper devicethe results were observed by a portable reader. As a result, the detection limit of the C-Reactive Protein is 1 ng/mL, with a total turnaround time of 7 min.

This rapid diagnostic device for monitoring the abnormal growth of the endometrial tissue is expected to allow women to detect whether VEGFIL-6 are too high at home in a simplerapid manner. These two factors are also increasing in some gynecological cancers. Through the new device, it is convenient for women to self-monitoring women physiologically-relevant diseasespossible causes of abnormal bleeding in the future,seek appropriate medical treatment early.